Confo Therapeutics
Graeme is a Professor of Molecular Pharmacology, Dean of Research at the College of Medical, Veterinary and Life Sciences, and Gardiner Professor of Biochemistry, University of Glasgow (Scotland). His research group centers on the function, structure and regulation of GPCRs and their interacting proteins, and has produced more than 500 peer-reviewed articles totaling more than 22,000 citations. In 2015 he co-founded Caldan Therapeutics, which discovers novel therapeutics for metabolic and inflammatory diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.